Estrogen receptor‐β ligand treatment modulates dendritic cells in the target organ during autoimmune demyelinating disease
Open Access
- 19 November 2010
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 41 (1), 140-150
- https://doi.org/10.1002/eji.201040796
Abstract
Estrogens act upon nuclear estrogen receptors (ER) to ameliorate cell‐mediated autoimmune disease. As most immunomodulatory effects of estrogens in EAE have been attributed to the function of ER‐α, we previously demonstrated that ER‐β ligand treatment reduced disease severity without affecting peripheral cytokine production or levels of CNS inflammation, suggesting a direct neuroprotective effect; however, the effect of ER‐β treatment on the function of immune cells within the target organ remained unknown. Here, we used adoptive transfer studies to show that ER‐β ligand treatment was protective in the effector, but not the induction phase of EAE, as shown by decreased clinical disease severity with the preservation of axons and myelin in spinal cords. The analysis of the immune cell infiltrates in the CNS revealed that while ER‐β ligand treatment did not reduce overall levels of CNS inflammation, there was a decrease in the DC percentage, and these CNS DC had decreased TNF‐α production. Finally, experiments using DC deficient in ER‐β revealed that the expression of ER‐β on DC was essential for protective effects of ER‐β ligand treatment in EAE. Our results demonstrate for the first time an effect of ER‐β ligand treatment in vivo on DC in the target organ of a prototypic cell‐mediated autoimmune disease.Keywords
This publication has 44 references indexed in Scilit:
- GPR30, but not estrogen receptor-α, is crucial in the treatment of experimental autoimmune encephalomyelitis by oral ethinyl estradiolBMC Immunology, 2010
- Estrogen treatment in multiple sclerosisJournal of the Neurological Sciences, 2009
- Estrogen treatment decreases matrix metalloproteinase (MMP)-9 in autoimmune demyelinating disease through estrogen receptor alpha (ERα)Laboratory Investigation, 2009
- Immune Regulatory Neural Stem/Precursor Cells Protect from Central Nervous System Autoimmunity by Restraining Dendritic Cell FunctionPLOS ONE, 2009
- Membrane Estrogen Receptor Regulates Experimental Autoimmune Encephalomyelitis through Up-regulation of Programmed Death 1The Journal of Immunology, 2009
- Intracerebral Dendritic Cells Critically Modulate Encephalitogenic versus Regulatory Immune Responses in the CNSJournal of Neuroscience, 2009
- Psoriasis Is Characterized by Accumulation of Immunostimulatory and Th1/Th17 Cell-Polarizing Myeloid Dendritic CellsJournal of Investigative Dermatology, 2009
- TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative diseaseJournal of Neuroinflammation, 2008
- Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER)α and ERβ ligand treatmentProceedings of the National Academy of Sciences of the United States of America, 2007
- The Estrogen Receptor -Isoform (ER ) of the Human Estrogen Receptor Modulates ER Transcriptional Activity and Is a Key Regulator of the Cellular Response to Estrogens and AntiestrogensEndocrinology, 1999